Pregled bibliografske jedinice broj: 1210947
Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities
Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities // International Journal of Pharmaceutics, 623 (2022), 121924, 16 doi:10.1016/j.ijpharm.2022.121924 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1210947 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cocrystals of tuberculosis antibiotics: Challenges
and missed opportunities
Autori
Salem, Ala' ; Khanfar, Esam ; Nagy, Sándor ; Széchenyi, Aleksandar
Izvornik
International Journal of Pharmaceutics (0378-5173) 623
(2022);
121924, 16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
CocrystalAnti-tuberculosisDrug-drug cocrystalSolubilityMultidrug-resistant
Sažetak
Cocrystals have been extensively used to improve the physicochemical properties and bioavailability of active pharmaceutical ingredients. Cocrystals of anti-tuberculosis medications are among those commonly reported. This review provides a summary of the tuberculosis antibiotic cocrystals reported in the literature, providing the main results on current tuberculosis medications utilized in cocrystals. Moreover, anti-tuberculosis cocrystals limitations and advantages are described, including evidence for enhanced solubility, stability and effect. Opportunities to enhance anti-tuberculosis medications and fixed dose combinations using cocrystals are given. Several cocrystal pairs are suggested to enhance the effectiveness of anti-tuberculosis drugs.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Kemijsko inženjerstvo, Farmacija
POVEZANOST RADA
Ustanove:
Sveučilište u Osijeku - Odjel za kemiju
Profili:
Aleksandar Secenji
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
